Geode Capital Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,583
| Closed | -$7.42K | – | 4666 |
|
|
2024
Q2 | $7.42K | Buy |
25,583
+2,974
| +13% | +$7.06K | ﹤0.01% | 4557 |
|
|
2024
Q1 | $325K | Buy |
22,609
+6,290
| +39% | +$75.3K | ﹤0.01% | 3771 |
|
|
2023
Q4 | $191K | Buy |
16,319
+5,769
| +55% | +$77.3K | ﹤0.01% | 3959 |
|
|
2023
Q3 | $158K | Buy |
10,550
+6,351
| +151% | +$110K | ﹤0.01% | 4073 |
|
|
2023
Q2 | $87.2K | Hold |
4,199
| – | – | ﹤0.01% | 4378 |
|
|
2023
Q1 | $37.8K | Sell |
4,199
-55
| -1% | -$667 | ﹤0.01% | 4581 |
|
|
2022
Q4 | $45K | Hold |
4,254
| – | – | ﹤0.01% | 4624 |
|
|
2022
Q3 | $60K | Hold |
4,254
| – | – | ﹤0.01% | 4726 |
|
|
2022
Q2 | $151K | Hold |
4,254
| – | – | ﹤0.01% | 4414 |
|
|
2022
Q1 | $426K | Buy |
4,254
+422
| +11% | +$56.1K | ﹤0.01% | 4019 |
|
|
2021
Q4 | $793K | Buy |
3,832
+2,872
| +299% | +$667K | ﹤0.01% | 3821 |
|
|
2021
Q3 | $337K | Buy |
+960
| New | +$310K | ﹤0.01% | 4211 |
|
